NLM Logo

Daclizumab MeSH Descriptor Data 2022


MeSH Heading
Daclizumab
Tree Number(s)
D12.776.124.486.485.114.224.060.766
D12.776.124.790.651.114.224.060.766
D12.776.377.715.548.114.224.200.766
Unique ID
D000077561
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077561
Scope Note
An anti-TAC (INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT) humanized monoclonal antibody (immunoglobulin G1 disulfide with human-mouse monoclonal clone 1H4 light chain, dimer) that is used in the treatment of ACUTE RELAPSING MULTIPLE SCLEROSIS.
Entry Term(s)
Dacliximab
Ro 24-7375
Ro-24-7375
Zenapax
Zinbryta
Pharm Action
Immunosuppressive Agents
Registry Number
CUJ2MVI71Y
Related Numbers
152923-56-3
Public MeSH Note
2019; DACLIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2018; and under ANTIBODIES, MONOCLONAL 1995-2011
History Note
2019 (1995)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/04/09
Daclizumab Preferred
Zinbryta Narrower
Zenapax Narrower
Ro 24-7375 Narrower
page delivered in 0.16s